![]() |
|
|
,2


* VA Alcohol Research Center, Department of Veterans Affairs Medical Center, Omaha, NE 68105 and
Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198
2To whom correspondence should be addressed. E-mail: ajbarak{at}yahoo.com.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: hepatocytes ethanol S-adenosylhomocysteine betaine phosphatidylethanolamine methyltransferase
Previous studies have shown that chronic ethanol administration alters methionine metabolism in the liver (1,2). Inhibition of methionine synthase (MS)2 activity appears to be a major defect elicited by ethanol consumption, resulting in impaired remethylation of homocysteine to form methionine (2,3). This defect ultimately leads to a decrease in hepatic levels of the universal methylating agent, S-adenosylmethionine (SAM) (2,4,5) and impaired methylation reactions (6). In addition, increased homocysteine, a potentially toxic agent, is generated and released from the liver as a consequence of impaired MS activity (7). Further studies showed that betaine, which can also provide methyl groups for the remethylation of homocysteine via betaine-homocysteine-methyltransferase (BHMT), prevented the ethanol-induced changes in methionine metabolism by restoring hepatic SAM levels (5,8) and by preventing the increased release of homocysteine by the liver (7). Furthermore, betaine was also shown to prevent and reverse ethanol-induced hepatic steatosis (5,8).
The purpose of the present study was to continue our work examining the ethanol-induced changes of hepatic methionine metabolism and the ability of betaine to reverse and/or counteract these alterations. Here, we investigated the effects of ethanol on hepatocyte S-adenosylhomocysteine (SAH) levels and the influence of betaine on these effects. Examination of SAH levels is important because SAH is the metabolic precursor of homocysteine and is formed as a product of methyl transfer reactions involving SAM (9). In addition, SAH has been shown to be a potential inhibitor of methyltransferases; therefore, it is an important regulator of methylation reactions in the cell (10,11).
Because dietary methionine was shown to elevate plasma homocysteine levels (12) and methionine loading in fasting patients is used to stress homocysteine pathways to reveal disturbances in methionine metabolism (13), the effect of methionine on hepatocyte levels of SAM and SAH in control and ethanol-fed rats was also studied. In addition, the effect of betaine under these conditions was investigated.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Nutritionally adequate liquid diets were formulated according to the method of Lieber and DeCarli (14) and purchased from Dyets (Bethlehem, PA). The ethanol-containing diet consisted of 18% of total energy as protein, 35% as fat, 11% as carbohydrate and 36% as ethanol. All control rats were pair-fed the same diet as the ethanol-fed rats except that ethanol was replaced isoenergetically with carbohydrate. Both ethanol-fed and control rats ingested identical amounts of all nutrients except carbohydrates.
Ethanol feeding procedure.
Male Wistar rats (Charles River Laboratories, Wilmington, MA) weighing 150175 g were initially fed the Purina 5001 diet (Ralston Purina, St. Louis, MO) until they reached body weights of 200220 g; they were then divided into two groups. The rats were housed individually and acclimated to the control diet for 3 d. These rats were then weight-matched and paired so that one rat received the liquid diet containing ethanol as 36% of total energy and the second was pair-fed the isoenergetic control diet. As with all of our previous studies with betaine, the rats were pair-fed for 4 wk. During the 24 h before isolation of hepatocytes, the liquid diets were fed in three portions: 25% at 0900 h, 50% at 1600 h and the final 25% at 0700 h. This meal-feeding regimen was used to minimize variations in feeding patterns between the ethanol-fed rats and their pair-fed controls before isolation of hepatocytes. The care and the use of the rats as well as all procedures were approved by the Institutional Animal Care and Use Committee at the Omaha Veterans Affairs Medical Center and were in accordance with the guidelines of the Institutional Care and Use Committee of the National Institute on Drug Abuse and the NIH (15).
Isolation of hepatocytes.
Hepatocytes were obtained from the livers of control and ethanol-fed rats by a modified collagenase-perfusion technique previously described by our laboratory (16). Viabilities of the different cell populations were determined by trypan blue exclusion, and only cell preparations attaining a viability of >85% were used. Cell suspensions (1 x 109 cells/L) were then incubated in Krebs-Hensleit buffer containing 12.5 mmol/L HEPES and 2.5 mmol/L Ca++ under an atmosphere of 95% O2/5% CO2. Before any treatment, cells were equilibrated for 30 min at 37°C. After this period, the cells were incubated for 4 h in the absence and presence of L-methionine (0.5 mmol/L), betaine (1.0 mmol/L) or methionine (0.5 mmol/L) plus betaine (1.0 mmol/L) at 37°C.
Measurement of SAM and SAH.
After incubation, hepatocyte suspensions were immediately centrifuged (150 x g for 5 min) to pellet the cells. The cell pellets were then treated with 0.5 mol/L HClO4, and the resulting supernatants were filtered through a Millipore membrane (0.22 µm; Millipore, Bedford, MA). The filtered acid extracts were subjected directly to HPLC for the determination of hepatocellular SAM and SAH levels, using the method described by Fu et al. (17).
Preparation of the hepatocyte microsomal fraction.
Hepatocytes, isolated from rats fed the Purina diet, were sonicated in ice-cold 10 mmol/L Tris HCl (pH, 7.4) containing 0.25 mol/L sucrose. The cell lysate was centrifuged at 16,000 x g for 20 min at 4°C and the supernatant was centrifuged again at 105,000 x g for 60 min at 4°C. The pellet of this last centrifugation (microsomal fraction) was resuspended in an appropriate volume of 0.25 mol/L sucrose, and protein content determined by the BCA (bicinchoninic acid) protein assay (Pierce, Rockford, IL) using bovine serum albumin (BSA) as the standard.
Phosphatidylethanolamine methyltransferase (PEMT) assay.
The PEMT activity in the microsomal fraction was determined by measuring the incorporation of [3H]methyl group from S-adenosyl-L-(methyl-3H) with endogenous microsomal phosphatidylethanolamine (PE) as the substrate (18). The concentration of SAM was kept constant (100 µmol/L). The concentration of SAH was varied to generate SAM:SAH ratios from 2.5 to 25, which correspond to the ratios in the hepatocytes of control or ethanol-fed rats under basal conditions and after methionine load and betaine administration. Briefly, the assay mixture (in a total volume of 500 µL) contained 10 mmol/L HEPES, pH 7.3, 0.25 mmol/L dithiothreitol, 5 mmol/L MgCl2, 100 µmol/L S-adenosyl-L-methionine, 74 kBq S-adenosyl-L-(methyl-3H)-methionine and 500 µg microsomal protein. SAH was added in varying amounts to the assay mixtures such that the ratio of SAM:SAH in the mixture was 2.5, 5, 7.5, 10 or 25. The reaction was initiated by the addition of a mixture of unlabeled and labeled S-adenosyl-L-(methyl-3H)-methionine, followed by a 10-min incubation at 37°C and was terminated by pipetting 100 µL of assay mixture in duplicate into 2 mL of chloroform/methanol/2 mol/L HCl (6:3:1) for lipid extraction. The aqueous phase was aspirated after centrifugation at 1800 x g for 5 min and the chloroform phase washed three times with 1 mL of 0.5 mol/L KCl in 50% methanol. After the last wash, the entire chloroform phase was pipetted into a counting vial, dried under a stream of nitrogen, dissolved into 8 mL of scintillation liquid and counted. The PEMT activity was expressed as pmol methylated PE products/(min · mg microsomal protein).
Statistics.
Results are expressed as means ± SEM. The data were analyzed by two-way ANOVA. Planned comparisons of treatment means were evaluated by direct contrasts of means using the statistical computer program Systat 9.0 (Richmond, CA). Differences between means were considered significant when P < 0.05. A one-tailed test was used for postulated unidirectional effects. Univariate repeated-measures ANOVA was used for determining the effects of different ratios on PEMT activity.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The results of this study identified another consequence of the ethanol-induced alterations of methionine metabolism. We observed a marked increase in SAH levels in hepatocytes from ethanol-fed rats, and these SAH levels were further elevated when the hepatocytes were incubated in the presence of methionine. In agreement with these results, others have also reported increases in SAH levels in livers of ethanol-fed rats (22,23). Elevated levels of SAH could have detrimental effects in the cell because this metabolite, rather than SAM, is an important indicator and regulator of cellular methylation status (10,11). The potential pathogenicity of intracellular SAH lies in its high affinity binding to the catalytic region of most SAM-dependent methyltransferases, enabling it to act as a potent product inhibitor, with Ki in the submicromolar to low micromolar range. In fact, the Ki for SAH is often less than the Km for SAM for many of the methyltransferases (24). Consistent with this, we demonstrated in this study that decreasing the SAM:SAH ratio by increasing the SAH levels under conditions of constant levels of SAM significantly decreased the activity of microsomal PEMT. Recent reports (25,26) suggested an important role for the phosphatidylcholine generated via the PEMT pathway in the formation of VLDL and transport of triglycerides from the liver. One of the earliest manifestations of ethanol-induced liver injury is the accumulation of triglycerides in the liver. Our present study supports the hypothesis that the decrease in the activity of PEMT due to the decreased intracellular SAM:SAH ratio in hepatocytes of ethanol-fed rats (leading to a defect in secretion of VLDL) may be responsible in part for the hepatic steatosis seen in these rats. The decrease in the SAM:SAH ratio may also be responsible for the impaired DNA methylation reported in rats fed intragastrically with ethanol and a high fat diet (21) by affecting the SAM-dependent DNA methyltransferases.
From the above, it is clear that removal of hepatic SAH is essential to correct the SAM:SAH ratio and the resultant defect in the transport of triglycerides from hepatocytes. The reaction that converts SAH to homocysteine and adenosine is reversible and catalyzed by SAH hydrolase. The thermodynamics of the reaction favor SAH synthesis over homocysteine synthesis; however, in vivo, the reaction proceeds toward hydrolysis only if the products are removed (9). The efficient removal of homocysteine also allows for the efficient removal of SAH. The most important finding of this study is that betaine, by remethylating homocysteine, is very effective in reducing the ethanol-induced elevation of SAH levels in isolated hepatocytes. Our previous study showed that betaine administration ameliorated ethanol-induced steatosis (8). On the basis of the results of this study, it is likely that betaine reduces the elevated SAH levels and corrects the defect in PEMT activity. Thus, in addition to promoting the generation of hepatic SAM, lowering homocysteine release from the liver and ameliorating steatosis (5,7,8), betaine is also effective in attenuating the elevation of SAH levels in the liver, increasing the SAM:SAH ratio and ultimately correcting the methylation defect elicited by chronic ethanol consumption. It is the decrease in the SAM:SAH ratio that appeared to be responsible for the reduced phosphatidylcholine synthesis and resultant steatosis and may also have been responsible for the altered signaling and genomic hypomethylation reported after ethanol consumption (21).
Despite the decrease in SAH levels when hepatocytes were incubated in the presence of both methionine and betaine, SAM levels did not increase correspondingly. This apparent paradoxical effect occurs because reduced SAH levels would result in decreased inhibition of hepatic methyltransferases, thus allowing increased utilization of SAM for methylation reactions. In addition, when hepatocytes from ethanol-fed rats were incubated in the presence of methionine, betaine reduced the increase in SAH levels but did not restore them to the low levels of controls (no methionine load). A likely explanation for these results is that under the stress of a methionine load in hepatocytes from ethanol-fed rats, betaine-elicited remethylation of homocysteine via BHMT is the only effective pathway operable because the alternate pathway for remethylation via MS is impaired by ethanol.
Overall, our data indicate that betaine, by virtue of its ability to remethylate homocysteine, lowers SAH levels, which in turn corrects defective cellular methylation and the resultant sequela of events of steatosis, DNA hypomethylation and altered signaling. Thus, betaine could be very effective in treating liver diseases as well as other diseases associated with elevated homocysteine and defective methylation.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
3 Abbreviations used: BHMT, betaine-homocysteine-methyltransferase; BSA, bovine serum albumin; MS, methionine synthase; PE, phosphatidylethanolamine; PEMT, phosphatidylethanolamine methyltransferase; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine. ![]()
Manuscript received 8 April 2003. Initial review completed 4 May 2003. Revision accepted 16 June 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. Tsukamoto, H. & Lu, S. C. (2001) Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 15:1335-1349.
2. Barak, A. J., Beckenhauer, H. C., Tuma, D. J. & Badakhsh, S. (1987) Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem. Cell Biol. 65:230-233.[Medline]
3. Barak, A. J., Beckenhauer, H. C. & Tuma, D. J. (1985) Ethanol feeding inhibits the activity of N5-methyltetrahydrofolate-homocysteine methyltransferase in the rat. IRCS Med. Sci. 13:760-761.
4. Barak, A. J., Beckenhauer, H. C., Tuma, D. J. & Donohue, T. M. (1984) Adaptive increase in betaine-homocysteine methyltransferase activity maintains hepatic S-adenosylmethionine levels in ethanol-treated rats. IRCS Med. Sci. 12:866-867.
5. Barak, A. J., Beckenhauer, H. C., Junnila, M. & Tuma, D. J. (1993) Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. Alcohol Clin. Exp. Res. 17:552-555.[Medline]
6. Cravo, M. L. & Camilo, M. E. (2000) Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B(6) and B(12) status. Nutrition 16:296-302.[Medline]
7. Barak, A. J., Beckenhauer, H. C., Kharbanda, K. K. & Tuma, D. J. (2001) Chronic ethanol consumption increases homocysteine accumulation in hepatocytes. Alcohol 25:77-81.[Medline]
8. Barak, A. J., Beckenhauer, H. C., Badakhsh, S. & Tuma, D. J. (1997) The effect of betaine in reversing alcoholic steatosis. Alcohol Clin. Exp. Res. 21:1100-1102.[Medline]
9. Finkelstein, J. D. (1990) Methionine metabolism in mammals. J. Nutr. Biochem. 1:228-237.[Medline]
10. Kerr, S. J. & Heady, J. E. (1974) Modulation of tRNA methyltransferase activity by competing enzyme systems. Adv. Enzyme Regul. 12:103-117.[Medline]
11. Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P., Hine, R. J. & James, S. J. (2000) Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275:29318-29323.
12. Finkelstein, J. D., Martin, J. J., Harris, B. J. & Kyle, W. E. (1982) Regulation of the betaine content of rat liver. Arch. Biochem. Biophys. 218:169-173.[Medline]
13. Refsum, H., Fiskerstrand, T., Guttormsen, A. B. & Ueland, P. M. (1997) Assessment of homocysteine status. J. Inherit. Metab. Dis. 20:286-294.[Medline]
14. Lieber, C. S. & DeCarli, L. M. (1989) Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol 24:197-211.
15. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council (1996) Guide for the Care And Use of Laboratory Animals 1996 National Academy Press Washington, DC.
16. Casey, C. A., Kragskow, S. L., Sorrell, M. F. & Tuma, D. J. (1987) Chronic ethanol administration impairs the binding and endocytosis of asialo-orosomucoid in isolated rat hepatocytes. J. Biol. Chem. 262:2704-2710.
17. Fu, W., Dudman, N. P., Perry, M. A., Young, K. & Wang, X. L. (2000) Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine. Biochem. Biophys. Res. Commun. 271:47-53.[Medline]
18. Duce, A. M., Ortiz, P., Cabrero, C. & Mato, J. M. (1988) S-Adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 8:65-68.[Medline]
19. Stickel, F., Choi, S. W., Kim, Y. I., Bagley, P. J., Seitz, H. K., Russell, R. M., Selhub, J. & Mason, J. B. (2000) Effect of chronic alcohol consumption on total plasma homocysteine level in rats. Alcohol Clin. Exp. Res. 24:259-264.[Medline]
20. Hultberg, B., Berglund, M., Andersson, A. & Frank, A. (1993) Elevated plasma homocysteine in alcoholics. Alcohol Clin. Exp. Res. 17:687-689.[Medline]
21. Lu, S. C., Huang, Z. Z., Yang, H., Mato, J. M., Avila, M. A. & Tsukamoto, H. (2000) Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am. J. Physiol. 279:G178-G185.
22. Trimble, K. C., Molloy, A. M., Scott, J. M. & Weir, D. G. (1993) The effect of ethanol on one-carbon metabolism: increased methionine catabolism and lipotrope methyl-group wastage. Hepatology 18:984-989.[Medline]
23. Halsted, C. H., Villanueva, J., Chandler, C. J., Stabler, S. P., Allen, R. H., Muskhelishvili, L., James, S. J. & Poirier, L. (1996) Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology 23:497-505.[Medline]
24. Clarke, S. & Banfield, K. (2001) S-Adenosylmethionine-dependent methyltransferases. Carmel, R. Jackobsen, D. W. eds. Homocysteine in Health and Disease 2001:63-78 Cambridge University Press Cambridge, UK. .
25. Noga, A. A., Zhao, Y. & Vance, D. E. (2002) An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J. Biol. Chem. 277:42358-42365.
26. Zhu, X., Song, J., Mar, M. H., Edwards, L. J. & Zeisel, S. H. (2003) Phosphatidylethanolamine-N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochem. J. 370:987-993.[Medline]
This article has been cited by other articles:
![]() |
Z. Zhou, J. Liu, Z. Song, C. J. McClain, and Y. J. Kang Zinc Supplementation Inhibits Hepatic Apoptosis in Mice Subjected to a Long-Term Ethanol Exposure Experimental Biology and Medicine, May 1, 2008; 233(5): 540 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Purohit, M. F Abdelmalek, S. Barve, N. J Benevenga, C. H Halsted, N. Kaplowitz, K. K Kharbanda, Q.-Y. Liu, S. C Lu, C. J McClain, et al. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium Am. J. Clinical Nutrition, July 1, 2007; 86(1): 14 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fardet, C. Canlet, G. Gottardi, B. Lyan, R. Llorach, C. Remesy, A. Mazur, A. Paris, and A. Scalbert Whole-Grain and Refined Wheat Flours Show Distinct Metabolic Profiles in Rats as Assessed by a 1H NMR-Based Metabonomic Approach J. Nutr., April 1, 2007; 137(4): 923 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bailey, G. Robinson, A. Pinner, L. Chamlee, E. Ulasova, M. Pompilius, G. P. Page, D. Chhieng, N. Jhala, A. Landar, et al. S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G857 - G867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hanje, B. Fortune, M. Song, D. Hill, and C. McClain The Use of Selected Nutrition Supplements and Complementary and Alternative Medicine in Liver Disease Nutr Clin Pract, June 1, 2006; 21(3): 255 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Chiuve, E. L Giovannucci, S. E Hankinson, D. J Hunter, M. J Stampfer, W. C Willett, and E. B Rimm Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine Am. J. Clinical Nutrition, July 1, 2005; 82(1): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Kharbanda, D. D. Rogers II, M. E. Mailliard, G. L. Siford, A. J. Barak, H. C. Beckenhauer, M. F. Sorrell, and D. J. Tuma A Comparison of the Effects of Betaine and S-Adenosylmethionine on Ethanol-Induced Changes in Methionine Metabolism and Steatosis in Rat Hepatocytes J. Nutr., March 1, 2005; 135(3): 519 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Craig Betaine in human nutrition Am. J. Clinical Nutrition, September 1, 2004; 80(3): 539 - 549. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||